SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-097812
Filing Date
2021-07-29
Accepted
2021-07-29 20:52:36
Documents
2
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2123556-5_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2123556-5_3seq1.xml 3 5365
2 EXHIBIT 24 tm2123556d5_ex24.htm EX-24 9491
  Complete submission text file 0001104659-21-097812.txt   16236
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Issuer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNEERING CORPORATION 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address
Barrett Scott (Reporting) CIK: 0001869953 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40675 | Film No.: 211129538